Search for: "Martin v. American General Finance Inc"
Results 1 - 20
of 49
Sorted by Relevance
|
Sort by Date
8 Oct 2007, 7:38 am
The answer, conveniently forgotten on the cutting room floor, involves the one topic around which all American businesses pivot: finances. [read post]
27 Jun 2018, 9:01 pm
The low-profile case with a tax angle that I mentioned at the beginning of this column is Wisconsin Central Ltd. v. [read post]
3 Dec 2009, 12:13 am
They've cited, most recently, the Court's 5-4 decision this year in Ashcroft v. [read post]
23 Jan 2009, 1:00 am
(Managing Intellectual Property) (Law360) (Out-Law) ECJ rules German music distributor cannot sell two Bob Dylan compilation albums because Sony owns rights to songs in question: Sony Music Entertainment (Germany) GmbH v Falcon Neue Medien Vertrieb GmbH (IPKat) (Law360) ECJ: Date set for Advocate General’s opinion in L'Oréal SA, Lancôme parfums et beauté & Cie SNC, Laboratoire Garnier & Cie v Bellure NV,… [read post]
17 Nov 2007, 3:59 am
The CIT Group/ Consumer Finance, Inc. [read post]
25 Mar 2011, 2:29 pm
Solicitor General, speaking for the federal government as amicus. [read post]
11 Jan 2017, 9:01 am
In Minnesota Citizens Concerned for Life, Inc. v. [read post]
18 Jun 2018, 7:51 am
Martin, Mitali Nagrecha, Mary Pattillo, Alex R. [read post]
5 Mar 2018, 9:32 am
Martin, Mitali Nagrecha, Mary Pattillo, Alex R. [read post]
13 Aug 2021, 4:00 am
Since he became postmaster general, DeJoy has divested between $65.4 million and $155.3 million worth of XPO shares. [read post]
26 Aug 2022, 4:00 am
While amendments such as the one Cawthorn filed are not uncommon, ones that show large changes can trigger FEC action, said FEC spokesperson Mills Martin. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex… [read post]
23 Mar 2012, 7:31 am
Frye and Lafler v. [read post]
17 Dec 2009, 6:33 am
Emmerich, Sabastian V. [read post]
9 Aug 2008, 1:50 am
: (Patenting Lives), Worldwide increase in patent filings puts strain on system: (Managing Intellectual Property), WIPO releases 2008 Worldwide Patent Report: (Peter Zura's 271 Patent Blog), (Patent Prospector), (IP Updates), Global patent filings continue rise but may level off; smaller nationals slipping: (Intellectual Property Watch), Means plus function: Don’t ignore the man behind the curtain: (Intellectual Property Directions), Technology start-up entrepreneurs and CEOs: If your… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
16 Sep 2009, 1:47 pm
(Worcester, MA; Jose Silva, President) American Projects Funding And Private Financing Arrangments, Inc. [read post]
23 Oct 2023, 12:00 am
The National World website has debuted the UK’s first AI-generated weather presenter, Press Gazette reports. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
28 Jan 2023, 7:32 am
Greater comparability of climate transition methodologies, as well as transparency and interpretability of climate finance and ESG metrics are urgently needed. [read post]
